SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-003595
Filing Date
2021-01-28
Accepted
2021-01-28 13:43:45
Documents
1
Period of Report
2021-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10802
  Complete submission text file 0000899243-21-003595.txt   13378
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Issuer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Reporting) CIK: 0001080014 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37544 | Film No.: 21563932
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1209 ORANGE STREET WILMINGTON DE 19801
Business Address 1209 ORANGE STREET WILMINGTON DE 19801 877 202 1097
Innoviva Strategic Opportunities LLC (Reporting) CIK: 0001842875 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37544 | Film No.: 21563933